- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Barotrauma.
Displaying page 1 of 1.
EudraCT Number: 2008-000444-13 | Sponsor Protocol Number: X16012008 | Start Date*: 2008-04-08 | |||||||||||
Sponsor Name:Finnish Defence Forces | |||||||||||||
Full Title: Äkillisen akustisen vamman hoito ylipaineisella happihoidolla ja lääkkeillä: Prospektiivinen satunnaistettu ja kontrolloitu tutkimus vamman saaneilla varusmiehillä. | |||||||||||||
Medical condition: Acustic or barotraumas after gun accident in conscripts | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003168-37 | Sponsor Protocol Number: Thllo | Start Date*: 2019-05-13 |
Sponsor Name:University Tuebingen | ||
Full Title: Therapeutic Iloprost for the treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial): a prospective, randomized, multicenter phase II study | ||
Medical condition: Acute respiratory distress syndrome requiring mechanical ventilation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-000140-13 | Sponsor Protocol Number: FPCLI001 | Start Date*: 2008-05-09 |
Sponsor Name:Faron Pharmaceuticals Limited | ||
Full Title: A Phase I/II Open–Label study to Assess the Safety, Tolerability and Preliminary Efficacy of FP-1201 (Recombinant Human Interferon Beta) in the treatment of patients with Acute Lung Injury and Acut... | ||
Medical condition: Acute Lung Injury/Acute Respiratory Distress Syndrome (ALI/ARDS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002550-30 | Sponsor Protocol Number: DM/PR/5000/003/05 | Start Date*: 2006-11-09 |
Sponsor Name:Chiesi Farmaceutici S. p. A. | ||
Full Title: A randomized controlled pilot study for the comparison of efficacy of bronchoalveolar lavage (BAL) with Curosurf® in a dosage 50 mg/kg vs not treated control in adult patients affected by pulmonary... | ||
Medical condition: lung contusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005587-26 | Sponsor Protocol Number: AM-101-CL-12-01 | Start Date*: 2014-05-27 | |||||||||||
Sponsor Name:Auris Medical Inc. | |||||||||||||
Full Title: Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 2 (TACTT2) | |||||||||||||
Medical condition: Acute peripheral tinnitus following traumatic cochlear injury or otitis media | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005384-24 | Sponsor Protocol Number: AM-101-CL-10-02 | Start Date*: 2012-02-06 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: TACTT1 | |||||||||||||
Medical condition: Acute inner ear tinnitus following acute acustic trauma, acute otitis media, middle ear surgery, or inner ear barotrauma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004099-20 | Sponsor Protocol Number: AM-101-CL-12-02 | Start Date*: 2013-10-30 | |||||||||||
Sponsor Name:Auris Medical AG | |||||||||||||
Full Title: Efficacy and Safety of AM-101 in the Treatment of Acute Peripheral Tinnitus 3 (TACTT3) | |||||||||||||
Medical condition: acute peripheral tinnitus following traumatic cochlear injury or otitis media | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) DE (Completed) AT (Completed) GB (Completed) PL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003913-21 | Sponsor Protocol Number: NL78575.018.21 | Start Date*: 2022-07-20 | ||||||||||||||||||||||||||
Sponsor Name:Amsterdam UMC | ||||||||||||||||||||||||||||
Full Title: A Prospective, Open-label Pilot Study to Evaluate Effector mechanisms of Hyperbaric Oxygen Therapy in Patients with Moderate-to-Severe Ulcerative Colitis: The PARADOX study | ||||||||||||||||||||||||||||
Medical condition: Ulcerative colitis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
